Nayyara Sultana Dawood, MD
Pediatrics · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dawood’s office at (408) 279-8786 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A63743 · Current
Licensed to practise in California · since 1997 · expires 2027-10-31 · University of Madras, Madras Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$14,333 in 2024
Medicaid paid $14,333 for 949 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 387 | $6,834 |
| Screening test, pure tone, air only | 194 | $2,004 |
| Developmental screening | 148 | $1,715 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 12 | $1,462 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 12 | $864 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 17 | $822 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 71 | $357 |
| Screening performed and negative | 108 | $274 |
| 2024 | 949 | 8 | 42 | $14,333 |
| 2023 | 1,384 | 9 | 68 | $12,328 |
| 2022 | 1,834 | 11 | 76 | $18,420 |
| 2021 | 1,521 | 10 | 66 | $14,277 |
| 2020 | 1,506 | 13 | 55 | $17,732 |
| 2019 | 1,317 | 9 | 51 | $17,461 |
| 2018 | 1,563 | 11 | 67 | $16,246 |
See the largest Medicaid services in earlier years
2023
| Screening test, pure tone, air only | 251 | $2,611 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 35 | $2,166 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 38 | $1,826 |
| Developmental screening | 193 | $1,627 |
| Short return visit (20+ min) | 700 | $1,513 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 12 | $1,241 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 24 | $489 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 90 | $458 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 41 | $396 |
2022
| Screening test, pure tone, air only | 308 | $3,180 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 58 | $2,724 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 45 | $2,723 |
| Developmental screening | 230 | $2,716 |
| Short return visit (20+ min) | 868 | $2,551 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 52 | $1,546 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 191 | $977 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose | 14 | $560 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 13 | $536 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose | 12 | $480 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 43 | $428 |
2021
| Screening test, pure tone, air only | 303 | $3,057 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 48 | $2,955 |
| Short return visit (20+ min) | 706 | $2,096 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 46 | $2,058 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 197 | $1,006 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 78 | $792 |
| Developmental screening | 96 | $752 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose | 17 | $640 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 16 | $518 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 14 | $403 |
2020
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 60 | $3,812 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 59 | $3,011 |
| Screening test, pure tone, air only | 258 | $2,832 |
| Short return visit (20+ min) | 563 | $2,382 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 140 | $1,461 |
| Developmental screening | 77 | $1,281 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 26 | $1,147 |
| Return visit (30+ min) | 105 | $516 |
| Long return visit (40+ min) | 80 | $488 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 88 | $444 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 21 | $213 |
| MEASURE BLOOD OXYGEN LEVEL | 14 | $86 |
2019
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 92 | $4,239 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 60 | $3,670 |
| Screening test, pure tone, air only | 331 | $3,620 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 50 | $2,007 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 174 | $1,606 |
| Short return visit (20+ min) | 311 | $1,025 |
| MEASURE BLOOD OXYGEN LEVEL | 134 | $733 |
| Long return visit (40+ min) | 90 | $280 |
| Return visit (30+ min) | 75 | $279 |
2018
| Screening test, pure tone, air only | 308 | $3,334 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 71 | $3,325 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 37 | $2,174 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 203 | $2,121 |
| Return visit (30+ min) | 280 | $2,059 |
| Short return visit (20+ min) | 355 | $2,045 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 228 | $890 |
| MEASURE BLOOD OXYGEN LEVEL | 28 | $142 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 23 | $122 |
| Bilateral quantitative screening test of visual acuity | 13 | $36 |
| Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument | 17 | $0 |
Money from drug and device companies
$29 in 2025
| 2025 | 1 | 1 | None | $29 |
| 2023 | 2 | 2 | None | $50 |
| 2021 | 2 | 2 | None | $43 |
| 2019 | 1 | 2 | None | $32 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ARS Pharmaceuticals Operations | Neffy | $29 | 1 payment
|
See the published payment
| ARS Pharmaceuticals Operations | Meals · 2025-08-08 | Neffy | $29 |
See earlier years (2023, 2021, 2019)
2023: $50
| Sanofi Pasteur | Vaxelis | $27 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Flumist Quadrivalent | $23 | 1 payment
|
2021: $43
| GlaxoSmithKline | Bexsero | $31 | 1 payment
|
| Cranial Technologies | Doc Band | $12 | 1 payment
|
2019: $32
| Sanofi Pasteur | Pentacel | $32 | 2 payments
|
Professional record
- NPI
- 1194744391
- Licence
- CA A63743California A63743: Current · expires 2027-10-31
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A637430
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 275 Oconnor Dr Ste C, San Jose, CA, 95128
- NPI first listed
- 2006-07-19
- NPI last updated
- 2016-05-04
This is when the NPI record was last certified, not a medical board exam.